Agno Pharma Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
500
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Agno Pharma General Information
Description
Provider of contract development and manufacturing services intended for the pharmaceutical and biotech industries. The company provides end-to-end contract development and manufacturing services through a network of FDA-inspected facilities that support complex chemistry and sterile drug product formulations, providing regulatory starting materials, intermediates, active pharmaceutical ingredients, sterile drug products, drug implants, and analytical characterization to help clients deliver pharmaceutical products to market.
Contact Information
Website
www.agnopharma.comCorporate Office
- 3894 Courtney Street
- Bethlehem, PA 18017
- United States
Corporate Office
- 3894 Courtney Street
- Bethlehem, PA 18017
- United States
Agno Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 01-Aug-2024 | Completed | Generating Revenue |
Agno Pharma Comparisons
Industry
Financing
Details
Agno Pharma Competitors (26)
One of Agno Pharma’s 26 competitors is Dalton Pharma Services, a Corporate Backed or Acquired company based in Toronto, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dalton Pharma Services | Corporate Backed or Acquired | Toronto, Canada | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Biotest | Formerly PE-Backed | Dreieich, Germany | ||||
| Cytovance Biologics | Formerly PE-Backed | Oklahoma City, OK | ||||
| AbbVie | Corporation | North Chicago, IL |
Agno Pharma Signals
Agno Pharma Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bain Capital | PE/Buyout | Minority | ||
| Vivo Capital | Venture Capital | Minority |
Agno Pharma Acquisitions (2)
Agno Pharma’s most recent deal was a Merger/Acquisition with Cascade Chemistry. The deal was made on 15-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cascade Chemistry | 15-Jan-2026 | Merger/Acquisition | BPO/Outsource Services | ||
| Lubrizol Particle Sciences | 18-Dec-2023 | Merger/Acquisition | Drug Discovery |
Agno Pharma FAQs
-
When was Agno Pharma founded?
Agno Pharma was founded in 2004.
-
Where is Agno Pharma headquartered?
Agno Pharma is headquartered in Bethlehem, PA.
-
What is the size of Agno Pharma?
Agno Pharma has 500 total employees.
-
What industry is Agno Pharma in?
Agno Pharma’s primary industry is Pharmaceuticals.
-
Is Agno Pharma a private or public company?
Agno Pharma is a Private company.
-
What is Agno Pharma’s current revenue?
The current revenue for Agno Pharma is .
-
Who are Agno Pharma’s investors?
Bain Capital and Vivo Capital have invested in Agno Pharma.
-
Who are Agno Pharma’s competitors?
Dalton Pharma Services, Cipla, Biotest, Cytovance Biologics, and AbbVie are some of the 26 competitors of Agno Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process